2,063
Views
0
CrossRef citations to date
0
Altmetric
Special Focus Issue: Frontiers in Nucleic Acid-Based Drug R&D – Foreword

Frontiers in Nucleic Acid-Based Drug Research and Development

&
Pages 1619-1621 | Published online: 14 Oct 2015

References

  • Guncay A , YokotaT. Antisense oligonucleotide drugs for Duchenne muscular dustropy: how far have we come and what does the future hold?Future Med. Chem.7 (13), 1631–1635 (2015).
  • Vocelle D , ChanC, WaltonSP. How can novel microscopic approaches shed light on the function of nucleic acid-based drugs ? Future Med. Chem.7 (13), 1623–1626 (2015).
  • Romanelli A . Exploring the dark matter of the human genome using oligonucleotide-based molecules. Future Med. Chem.7 (13), 1627–1630 (2015).
  • Kurreck J . Application of modified antisense oligonucleotides and siRNAs an antiviral drugs. Future Med. Chem.7 (13), 1637–1642 (2015).
  • Fu S , SunLQ. DNAzyme-based therapeutics for cancer treatment. Future Med. Chem.7 (13), 1701–1707 (2015).
  • Yu J , SahuP, KimGet al. Design, synthesis and cellular metabolism study of 4′-selenonucleosides. Future Med. Chem.7 (13), 1643–1655 (2015).
  • Sizun G , PierraC, PeyronnetJet al. Design, synthesis, and antiviral evaluation of 2′-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor. Future Med. Chem.7 (13), 1675–1700 (2015).
  • Wong JP . Nucleic acid-based drugs against emerging zoonotic viruses. Future Med. Chem.7 (13), 1709–1719 (2015).
  • Bessieres B , ChevrierF, RoyV, AgrofoglioLA. Recent progress for the synthesis of selected carbocyclic nucleosides. Future Med. Chem.7 (13), 1809–1828 (2015).
  • Singh NS , LeeBM, DiDonatoCJ, SinghRN. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. Future Med. Chem.7 (13), 1793–1808 (2015).
  • Bernardo BC , OoiJYY, LinRCY, McMullenJR. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med. Chem.7 (13), 1771–1792 (2015).
  • Lin PJC , TamYK. Enhanced the pharmacokinetic/pharmacodynamic properties of therapeutic nucleotides using liposomal delivery systems. Future Med. Chem.7 (13), 1751–1769 (2015).
  • Winkler J . Therapeutic oligonucleotides with polyethylene glycol modifications. Future Med. Chem.7 (13), 1721–1731 (2015).
  • Menzi M , LightfootH, HalJ. Polyamine–oligonocleotide conjugates: a promising direction for nucleic acid tools and therapeutics. Future Med. Chem.7 (13), 1733–1749 (2015).
  • Dirin M , UrbanE, LachmannB, NoeCR, WinklerJ. Concise postsynthetic preparation of oligonucleotide–oligopeptide conjugates through facile disulfide bond formation. Future Med. Chem.7 (13), 1657–1673 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.